Yuhong Zhang resumes & CV records
Resumes
Yuhong Zhang
Yuhong Zhang, 631290 N Pt Dr UNIT L, Stevens Point, WI 54481
Yuhong Zhang Phones & Addresses
Flushing, NY
Scranton, PA
Mentions for Yuhong Zhang
Publications & IP owners
Us Patents
Method Of Screening Test Substances For Treating Or Preventing A Disease Mediated By Plasma Cells
US Patent:
2003022, Dec 4, 2003
Filed:
Apr 11, 2003
Appl. No.:
10/413538
Inventors:
David Ron - New York NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
International Classification:
A61K031/00
C12Q001/68
G01N033/567
C12Q001/68
G01N033/567
US Classification:
435/006000, 435/007210, 514/001000
Abstract:
The present invention relates to a method of screening a compound for potential effectiveness in treating or preventing a mammalian disease mediated by plasma cells or a mammalian disease caused by virus infection of mammalian cells. Compounds are tested for their ability to inhibit IRE1-mediated processing of untranslatable XBP-1 mRNA into translatable XBP-1 mRNA. Drugs that are useful in treating or preventing a mammalian disease mediated by plasma cells and a method for detecting XBP-1 activity in living cells are also described.
Method Of Screening Test Substances For Treating Or Preventing A Disease Mediated By Plasma Cells
US Patent:
2010010, Apr 29, 2010
Filed:
Dec 30, 2009
Appl. No.:
12/649849
Inventors:
David Ron - New York NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Marcella Calfon - New York NY, US
Heather Harding - Brooklyn NY, US
Yuhong Zhang - Elmhurst NY, US
Assignee:
NEW YORK UNIVERSITY - New York NY
International Classification:
C12Q 1/68
C07H 21/02
C07H 21/02
US Classification:
435 6, 536 231
Abstract:
The present invention relates to a method of screening a compound for potential effectiveness in treating or preventing a mammalian disease mediated by plasma cells or a mammalian disease caused by virus infection of mammalian cells. Compounds are tested for their ability to inhibit IRE1-mediated processing of untranslatable XBP-1 mRNA into translatable XBP-1 mRNA. Drugs that are useful in treating or preventing a mammalian disease mediated by plasma cells and a method for detecting XBP-1 activity in living cells are also described.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.